Gen-Probe Q4 Revenues Grow 16 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Gen-Probe's fourth-quarter revenues rose 16 percent year over year as its blood screening business rose 30 percent, the company said after the close of the market on Monday.

For the three months ended Dec. 31, 2011, the San Diego company posted revenues of $158.2 million, up from $136.7 million a year ago, just short of analyst estimates calling for $158.6 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.